Zhongchao Inc ZCMD

NAS: ZCMD | ISIN: KYG9897X1079   14/11/2024
1,250 USD (+3,31%)
(+3,31%)   14/11/2024

12 maart 2024 · Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications · Persbericht

27 februari 2024 · Zhongchao Inc. Announces 1-for-10 Share Consolidation · Persbericht

11 december 2023 · Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments · Persbericht

23 oktober 2023 · Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day · Persbericht

25 september 2023 · Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients · Persbericht

24 augustus 2023 · Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management · Persbericht

11 juli 2023 · Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer Education · Persbericht

12 juni 2023 · Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment · Persbericht

12 mei 2023 · Zhongchao Inc. Announces Strategic Cooperation with Ximalaya · Persbericht

8 mei 2023 · Zhongchao Inc. Announces Naiditawei® Enrolled as a Listed Online Procurement Drug in Ten Provinces(Districts, Cities) in China · Persbericht

24 april 2023 · Zhongchao Inc. Partners with a Public Health Foundation to Safeguard Cancer Patients' Health · Persbericht

30 maart 2023 · Zhongchao Inc. Announces Launch of Health Education Intelligent Content Production Platform · Persbericht

13 maart 2023 · Zhongchao Inc. Releases Survey Results for Bone Marrow Cancer Patient Services with More than 80% Patients Indicating Full Satisfaction · Persbericht

23 februari 2023 · Zhongchao Inc. Renews Partnership with Johnson & Johnson (China) · Persbericht

13 februari 2023 · Zhongchao Inc. Announces the Application of ChatGPT for Its MDMOOC Platform to Assist Physicians in Clinic Decision Making and Improve Treatment Efficiency · Persbericht

8 februari 2023 · Zhongchao Inc. Announces the Application of ChatGPT to Elevate Patient Management Service Capabilities and Experience · Persbericht

31 januari 2023 · Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China · Persbericht

19 januari 2023 · Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment · Persbericht

4 januari 2023 · Zhongchao Inc. Announces Drug Distributorship in China of Indian Generic Drugs of Natco Pharma Limited · Persbericht

5 december 2022 · Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education Platform · Persbericht

Mijn selecties